Format

Send to

Choose Destination
Vaccine. 2004 Jun 23;22(19):2425-9.

Optimisation of a lipid based oral delivery system containing A/Panama influenza haemagglutinin.

Author information

1
Department of Immunology, University of Strathclyde, Arbuthnott Building, SIBS, 27 Taylor Street, Glasgow, G4 0NR, Scotland, UK.

Abstract

Vaccine antigens administered by the oral route are often degraded by gastric secretions during gastrointestinal transit. This necessitates larger and more frequent doses of antigen for vaccination. A delivery system, which overcomes this, is a lipid vesicle containing bile salts (bilosome), which prevents antigen degradation and enhances mucosal penetration. The effect of bilosome formulation modification on vaccine transit efficacy across the mucosa was determined. Specific antibody levels were assessed by end-point titre ELISA and the subclasses determined. Significant IgG1 titres were induced when the protein loading was doubled from 15 to 30 microg (P=0.009) and was equivalent to antigen administration by the subcutaneous route. No IgG2a was induced, indicating the generation of a TH2 response. Significant mucosal IgA levels were also observed with this treatment group (P=0.05).

PMID:
15193405
DOI:
10.1016/j.vaccine.2003.11.067
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center